To the best of our knowledge, it is the first time to report that ZLHXTY capsules could protect against intracerebral hemorrhage at earlier stages via inhibiting NFκB canonical signalling (Supplementary Figure S1). Here, NFKB1 is linked to intracerebral hemorrhage.